TipRanks
Advertisement
Advertisement

DE:C68 Stock Latest News

Crescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright
The FlyCrescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright
3h ago
CBIO
Crescent Biopharma announces FDA clearance of CR-002 IND application
PremiumThe Fly
Crescent Biopharma announces FDA clearance of CR-002 IND application
1d ago
CBIO
Analyst Backs Crescent Biopharma With Buy Rating on Advancing ADC Pipeline and Strong Cash Runway
PremiumRatings
Analyst Backs Crescent Biopharma With Buy Rating on Advancing ADC Pipeline and Strong Cash Runway
2M ago
CBIO
Crescent Biopharma reports Q2 EPS (74c), consensus (64c)
PremiumThe Fly
Crescent Biopharma reports Q2 EPS (74c), consensus (64c)
2M ago
CBIO
Crescent Biopharma, Inc. (CBIO) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Crescent Biopharma, Inc. (CBIO) Q2 Earnings Cheat Sheet
2M ago
CBIO
Fourteen new option listings and one option delisting on July 22nd
PremiumThe FlyFourteen new option listings and one option delisting on July 22nd
3M ago
ACOG
ARTV
Crescent Biopharma 8.095M share Spot Secondary priced at $14.50
Premium
The Fly
Crescent Biopharma 8.095M share Spot Secondary priced at $14.50
3M ago
CBIO
Crescent Biopharma files ordinary shares offering, no amount given
Premium
The Fly
Crescent Biopharma files ordinary shares offering, no amount given
3M ago
CBIO
BTIG says others may be interested in Apogee Therapeutics
PremiumThe Fly
BTIG says others may be interested in Apogee Therapeutics
4M ago
JNJ
NVS
Crescent Biopharma shareholders back directors, pay and auditor
PremiumCompany Announcements
Crescent Biopharma shareholders back directors, pay and auditor
4M ago
8K
CBIO
Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright
4M ago
CBIO
Crescent Biopharma reports Q1 EPS (70c), consensus (79c)
PremiumThe Fly
Crescent Biopharma reports Q1 EPS (70c), consensus (79c)
5M ago
CBIO
Crescent Biopharma management to meet with Cantor Fitzgerald
PremiumThe FlyCrescent Biopharma management to meet with Cantor Fitzgerald
6M ago
CBIO
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
Premium
The Fly
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
7M ago
CBIO
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
Premium
The Fly
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
7M ago
CBIO
Crescent Biopharma sees cash runway into 2028
PremiumThe Fly
Crescent Biopharma sees cash runway into 2028
7M ago
CBIO
Crescent Biopharma announces grants of inducement awards
PremiumThe Fly
Crescent Biopharma announces grants of inducement awards
8M ago
CBIO
Crescent Biopharma: Fast-Follower Potential of CR-001 and Strategic Partnerships Support Buy Rating and $25 Target
PremiumRatings
Crescent Biopharma: Fast-Follower Potential of CR-001 and Strategic Partnerships Support Buy Rating and $25 Target
8M ago
CBIO
Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
PremiumThe Fly
Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
8M ago
CBIO
Crescent Biopharma initiated with an Overweight at Piper Sandler
PremiumThe FlyCrescent Biopharma initiated with an Overweight at Piper Sandler
8M ago
CBIO
Crescent Biopharma initiated with a Buy at Guggenheim
Premium
The Fly
Crescent Biopharma initiated with a Buy at Guggenheim
9M ago
CBIO
SMMT
Crescent Biopharma files to sell 19.71M shares of common stock for holders
Premium
The Fly
Crescent Biopharma files to sell 19.71M shares of common stock for holders
9M ago
CBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >